Neurogene shares owned by UBS Group
Historical chart of UBS Group investment in Neurogene
Tip: Access up to 7 years of quarterly data
All positions including Neurogene held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurogene by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.9M | 228k | 17.33 |
| 2025-06-30 | $3.6M | 240k | 14.95 |
| 2025-03-31 | $2.4M | 209k | 11.71 |
| 2024-12-31 | $7.9M | 347k | 22.86 |
| 2024-09-30 | $215k | 5.1k | 41.96 |
| 2024-06-30 | $125k | 3.4k | 36.38 |
| 2024-03-31 | $495k | 9.7k | 50.90 |
| 2023-12-31 | $19k | 1.0k | 19.38 |